Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.
Splenocytes from inbred Wistar rats bearing a syngeneic squamous cell carcinoma (Spl) were fractionated by several techniques to characterize the lymphoid cells cytotoxic to the tumour in vitro. The anti-tumour cytotoxicity is presumably mediated primarily by T lymphocytes because it was greatly reduced by removal of T lymphocytes with heterologous anti-T serum plus complement but not by removal of other cell types. Cytotoxicity could be blocked at the tumour cell but not at the effector cell by sera taken late in tumour growth. Sera taken earlier in tumour growth could induce cytolysis of tumour cells by normal splenocytes but only if the tumour cells were treated with serum and washed before addition of the effector cells. Although splenocytes from normal and tumour-bearing rats were equally effective at lysing antibody-coated target cells it is unlikely that this mechanism is important in vivo as sera from early in tumour growth onwards contained factors (immune complexes?) which inhibited antibody-induced lymphocytolysis.
D000818:Animals; D000936:Antigen-Antibody Complex; D000961:Antilymphocyte Serum; D001769:Blood; D002294:Carcinoma, Squamous Cell / Q000276:immunology*; D002458:Cell Fractionation; D002469:Cell Separation; D002470:Cell Survival; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D006462:Hemolytic Plaque Technique; D037102:Lectins; D008213:Lymphocyte Activation; D009374:Neoplasms, Experimental / Q000276:immunology; D010586:Phagocytes / Q000276:immunology; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000936:Antigen-Antibody Complex; D000961:Antilymphocyte Serum; D037102:Lectins; D003165:Complement System Proteins